Evaluation of rotavirus vaccines in small animal models.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Methods in Molecular Medicine

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1385/1-59259-078-0:147PMID 21318860
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rotaviruses: Immunological Determinants of Protection Against Infection and Disease

  2008cited by this paper
• Detection and Characterization of Novel Rotavirus Strains in the United States

  1999cited by this paper
• Heterotypic protection from rotavirus infection in mice vaccinated with virus-like particles.

  1999cited by this paper
• Biochemical and immunologic comparison of virus-like particles for a rotavirus subunit vaccine.

  1999cited by this paper
• Heterotypic Protection and Induction of a Broad Heterotypic Neutralization Response by Rotavirus-Like Particles

  1999cited by this paper
• Subunit Rotavirus Vaccine Administered Parenterally to Rabbits Induces Active Protective Immunity

  1998cited by this paper
• Analysis of Host Range Restriction Determinants in the Rabbit Model: Comparison of Homologous and Heterologous Rotavirus Infections

  1998cited by this paper
• Synthesis of rotavirus-like particles in insect cells: comparative and quantitative analysis.

  1998cited by this paper
• Protective Immunity Induced by Oral Immunization with a Rotavirus DNA Vaccine Encapsulated in Microparticles

  1998cited by this paper
• Development of a Heterologous Model in Germfree Suckling Rats for Studies of Rotavirus Diarrhea

  1998cited by this paper
• Passive immunity to bovine rotavirus in newborn calves fed colostrum supplements from cows immunized with recombinant SA11 rotavirus core-like particle (CLP) or virus-like particle (VLP) vaccines

  1998cited by this paper
• Effect of Water-Based Microencapsulation on Protection against EDIM Rotavirus Challenge in Mice

  1998cited by this paper
• Oral Immunization with Recombinant Norwalk Virus-Like Particles Induces a Systemic and Mucosal Immune Response in Mice

  1998cited by this paper
• Protease susceptibility and toxicity of heat-labile enterotoxins with a mutation in the active site or in the protease-sensitive loop

  1997cited by this paper
• Rotavirus vaccines against diarrhoeal disease.

  1997cited by this paper
• Mutants in the ADP-ribosyltransferase Cleft of Cholera Toxin Lack Diarrheagenicity but Retain Adjuvanticity

  1997cited by this paper
• Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela.

  1997cited by this paper
• Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis.

  1997cited by this paper
• Protective immunity induced by rotavirus DNA vaccines.

  1997cited by this paper
• Particle bombardment-mediated DNA vaccination with rotavirus VP6 induces high levels of serum rotavirus IgG but fails to protect mice against challenge.

  1997cited by this paper
• Determination of the duration of a primary immune response and the ID50 of ALA rabbit rotavirus in rabbits

  1997cited by this paper
• Induction of cross-reactive cytotoxic T-lymphocyte responses specific for HIV-1 gp120 using saponin adjuvant (QS-21) supplemented subunit vaccine formulations.

  1997cited by this paper
• DNA immunization with a bovine rotavirus VP4 gene induces a Th1-like immune response in mice.

  1997cited by this paper
• Efficacy and safety of high-dose rhesus-human reassortant rotavirus vaccine in Native American populations.

  1997cited by this paper
• 5 – Use of Escherichia coli Heat-Labile Enterotoxin as an Oral Adjuvant

  1996cited by this paper
• Protection against rotavirus infections by DNA vaccination.

  1996cited by this paper
• Aqueous-based microencapsulation enhances virus-specific humoral immune responses in mice after parenteral inoculation.

  1996cited by this paper
• Virus-like particles as a rotavirus subunit vaccine.

  1996cited by this paper
• Host factors associated with protection against rotavirus disease: the skies are clearing.

  1996cited by this paper
• Visualization of ordered genomic RNA and localization of transcriptional complexes in rotavirus

  1996cited by this paper
• Jennerian and modified Jennerian approach to vaccination against rotavirus diarrhea using a quadrivalent rhesus rotavirus (RRV) and human-RRV reassortant vaccine.

  1996cited by this paper
• Trials of oral bovine and rhesus rotavirus vaccines in Finland: a historical account and present status.

  1996cited by this paper
• Rotavirus infection in infants as protection against subsequent infections.

  1996cited by this paper
• WC3 reassortant vaccines in children.

  1996cited by this paper
• Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity

  1995cited by this paper
• Structural and immunological characterization of the vaccine adjuvant QS-21.

  1995cited by this paper
• Oral inoculation of mice with low doses of microencapsulated, noninfectious rotavirus induces virus-specific antibodies in gut-associated lymphoid tissue.

  1995cited by this paper
• Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants.

  1995cited by this paper
• Analyses of homologous rotavirus infection in the mouse model.

  1995cited by this paper
• Enhancement by microencapsulation of rotavirus-specific intestinal immune responses in mice assessed by enzyme-linked immunospot assay and intestinal fragment culture.

  1995cited by this paper
• Characterization of VP4 and VP7 of a murine rotavirus (YR-1) isolated in Japan.

  1995cited by this paper
• Characterization of virus-like particles produced by the expression of rotavirus capsid proteins in insect cells

  1994cited by this paper
• Enhancement of rotavirus immunogenicity by microencapsulation.

  1994cited by this paper
• Rotavirus pathology and pathophysiology.

  1994cited by this paper
• Active immunity against rotavirus infection in mice is correlated with viral replication and titers of serum rotavirus IgA following vaccination.

  1994cited by this paper
• Clinical trials of live oral rotavirus vaccines: the Finnish experience.

  1993cited by this paper
• Immunodominance of the VP4 neutralization protein of rotavirus in protective natural infections of young children

  1993cited by this paper
• Persistence of intestinal antibody response to heterologous rotavirus infection in a murine model beyond 1 year

  1993cited by this paper
• Rotavirus vaccine administered parenterally induces protective immunity

  1993cited by this paper
• Psoralen preparation of antigenically intact noninfectious rotavirus particles.

  1992cited by this paper
• Active protection against rotavirus infection of mice following intraperitoneal immunization.

  1992cited by this paper
• Evidence that active protection following oral immunization of mice with live rotavirus is not dependent on neutralizing antibody.

  1992cited by this paper
• Serologic and mucosal immune response to rotavirus infection in the rabbit model

  1991cited by this paper
• Expression of rotavirus VP2 produces empty corelike particles

  1991cited by this paper
• Effect of site-directed mutagenic alterations on ADP-ribosyltransferase activity of the A subunit of Escherichia coli heat-labile enterotoxin

  1991cited by this paper
• Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex.

  1991cited by this paper
• Serum-neutralizing antibody to VP4 and VP7 proteins in infants following vaccination with WC3 bovine rotavirus

  1990cited by this paper
• Development of an adult mouse model for studies on protection against rotavirus

  1990cited by this paper
• Effects of antibody to rotavirus on protection of adults challenged with a human rotavirus.

  1989cited by this paper
• The effects of host age, virus dose, and virus strain on heterologous rotavirus infection of suckling mice.

  1988cited by this paper
• Protective Effect of WC3 Vaccine Against Rotavirus Diarrhea in Infants During a Predominantly Serotype 1 Rotavirus Season

  1988cited by this paper
• Pathogenicity of rotavirus in rabbits

  1988cited by this paper
• Rabbit model of rotavirus infection

  1988cited by this paper
• Trends in the Development of Baculovirus Expression Vectors

  1988cited by this paper
• A Manual of Methods for Baculovirus Vectors and Insect Cell Culture Procedures.

  1987cited by this paper
• Synthesis and immunogenicity of the rotavirus major capsid antigen using a baculovirus expression system

  1987cited by this paper
• Epidemiology of naturally occurring rotavirus infection in rabbits.

  1986cited by this paper
• Cultivation and characterization of three strains of murine rotavirus

  1986cited by this paper
• Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to surface proteins vp3 and vp7

  1986cited by this paper
• Rotavirus-associated diarrhea in a commercial rabbitry.

  1986cited by this paper
• Protection against rotavirus-induced gastroenteritis in a murine model by passively acquired gastrointestinal but not circulating antibodies

  1985cited by this paper
• Maternal antibody-mediated protection against gastroenteritis due to rotavirus in newborn mice is dependent on both serotype and titer of antibody.

  1985cited by this paper
• Kinetics of viral replication and local and systemic immune responses in experimental rotavirus infection

  1984cited by this paper
• A murine model for oral infection with a primate rotavirus (simian SA11)

  1984cited by this paper
• New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development.

  1983cited by this paper
• Association of iota-like toxin and Clostridium spiroforme with both spontaneous and antibiotic-associated diarrhea and colitis in rabbits

  1983cited by this paper
• Age-Dependent Rotavirus-Enterocyte Interactions 1

  1982cited by this paper
• Susceptibility of mice to rotavirus infection: effects of age and administration of corticosteroids

  1981cited by this paper
• Lapine rotavirus: preliminary studies on epizoology and transmission.

  1978cited by this paper
• Epizootic Diarrhea of Infant Mice: Identification of the Etiologic Agent

  1963cited by this paper
• STUDIES ON THE ETIOLOGY AND TRANSMISSION OF EPIDEMIC DIARRHEA OF INFANT MICE

  1957cited by this paper

• Maternal antibody interference contributes to reduced rotavirus vaccine efficacy in developing countries

  2020cites this paper
• Co-Expression of Anti-Rotavirus Proteins (Llama VHH Antibody Fragments) in Lactobacillus: Development and Functionality of Vectors Containing Two Expression Cassettes in Tandem

  2014cites this paper
• New Neonatal Porcine Diarrhea Syndrome in Denmark Characterization of the intestinal lesions and identification of the etiology

  2014cites this paper
• Host susceptibility to rotavirus infection and development of antibody-based immunotherapy

  2014cites this paper
• Puesta a punto del modelo murino de infección por rotavirus y la evaluación de modelos de vacunas

  2013cites this paper
• Animal models for neonatal diseases in humans.

  2013cites this paper
• Research priorities regarding rotavirus vaccine and intussusception: a meeting summary.

  2012cites this paper
• Immunological and biochemical characterisation of the NSP4 protein of human rotavirus strains RV4 and RV5

  2011cites this paper
• Reduction in morbidity of rotavirus induced diarrhoea in mice by yeast produced monovalent llama-derived antibody fragments.

  2006cites this paper
• II, 10. The rat model of rotavirus infection

  2003cites this paper
• Immunogenicity and protective efficacy of rotavirus 2/6-virus-like particles produced by a dual baculovirus expression vector and administered intramuscularly, intranasally, or orally to mice.

  2003cites this paper
• Group A Rotavirus Infection and Age-Dependent Diarrheal Disease in Rats: a New Animal Model To Study the Pathophysiology of Rotavirus Infection

  2002cites this paper